333 results on '"Babu, K Govind"'
Search Results
2. Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
3. Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment
4. Cancer care and outreach in the South Asian Association for Regional Cooperation (SAARC) region: overcoming barriers and addressing challenges
5. A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors
6. Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
7. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
8. Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck - Update 2023.
9. Indian clinical practice consensus guidelines for the management of locoregional laryngeal cancer - Update 2023.
10. Indian clinical practice consensus guidelines for the management of oropharyngeal cancer - Update 2023.
11. Indian clinical practice consensus guidelines for the management of locoregional hypopharyngeal cancer - Update 2023.
12. Indian clinical practice consensus guidelines for the management of oral cavity cancer - Update 2023.
13. Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer - Update 2023.
14. Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer
15. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
16. Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care
17. Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 2022
18. Indian clinical practice consensus guidelines for the management of hypopharyngeal cancer: Update 2022
19. Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022
20. Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022
21. Indian clinical practice post-treatment imaging guidelines for head-and-neck cancers
22. Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022
23. Introduction to Indian clinical practice consensus guidelines for the management of squamous cell carcinoma the head-and-neck: Update 2022
24. Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast...
25. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
26. Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
27. Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection
28. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
29. Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India
30. Efficacy and Safety of Nuvastatic™ in Improving Cancer-related Fatigue: A Phase II Multicenter Randomized Controlled Trial
31. Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
32. Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference
33. sj-docx-1-tam-10.1177_17588359221081203 ��� Supplemental material for Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2��� advanced breast cancer
34. Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India
35. Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer
36. Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
37. Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region
38. Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib
39. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients
40. “Choosing Wisely” for Cancer Care in India
41. Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
42. Trastuzumab Emtansine: Antibody-drug Conjugate in Treatment of Human Epidermal Growth Factor Receptor-2-Positive Metastatic Breast Cancer
43. Patterns and the Occurrence of KRAS Mutations in Metastatic Colorectal Cancers—a Study from Indian Regional Cancer Centre
44. “Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic
45. A Novel Ex Vivo System Using 3D Polymer Scaffold to Culture Circulating Tumor Cells from Breast Cancer Patients Exhibits Dynamic E-M Phenotypes
46. Metastatic Synovial Sarcoma: Experience from a Tertiary Care Center from India
47. Pattern of Bone Marrow Involvement by Solid Tumors: Experience from a Tertiary Care Center from South India
48. Efficacy of a Reduced-dose Rasburicase: Single-institution Experience in India
49. Report on Our Publication in Science Reports
50. Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.